## **Core Concept**
The question tests the understanding of medications that are safe to use in asthmatic patients, focusing on potential bronchoconstrictive effects. Asthma is a condition characterized by episodic airway constriction, inflammation, and hyperreactivity. Medications that can trigger or worsen bronchoconstriction are generally avoided.

## **Why the Correct Answer is Right**
Propranolol is a non-selective beta-blocker. Non-selective beta-blockers can cause bronchoconstriction by blocking β2 receptors in the lungs, which are responsible for dilating airways. However, among the options given, only one can be identified as safe based on its pharmacological properties. **Atenolol** is a **selective β1-blocker**. It primarily affects the heart, reducing heart rate and myocardial contractility with less effect on β2 receptors in the bronchial smooth muscle, making it safer for use in asthmatic patients compared to non-selective beta-blockers.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Propranolol is a **non-selective beta-blocker** that can precipitate bronchospasm in asthmatic patients by blocking β2 receptors, making it less safe.
- **Option B:** Metoprolol is also a **selective β1-blocker** but like atenolol, its use needs caution; however, it is not the best answer provided here based on the context of the question.
- **Option C:** Nadolol is a **non-selective beta-blocker** with a long duration of action, which can also induce bronchospasm.
- **Option D:** This seems to be missing a specific drug but based on the correct answer provided, we focus on the properties of Atenolol.

## **Clinical Pearl / High-Yield Fact**
A crucial point to remember is that while **selective β1-blockers** like atenolol are safer in asthma, they are not completely risk-free, and their use should be cautious, especially in patients with severe asthma or those with a history of severe bronchospasm. Always consider alternative treatments if possible.

## **Correct Answer:** . Atenolol